Please assess the completion status of the following clinical trial:

Trial Title: Employment-Based Depot Naltrexone Clinical Trial II

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Individuals were eligible if they:~* met the Diagnostic and Statistical Manual (DSM)-IV criteria for opioid dependence,~* reported using heroin at least 21 of the last 30 days while living in the community,~* were unemployed,~* were 18-65 years old,~* were medically approved for naltrexone,~* lived in or near Baltimore, MD.~Individuals were excluded if they:~* were pregnant or breastfeeding,~* had serum aminotransferase levels over three times normal,~* had current hallucinations, delusions, or thought disorders, current suicidal or -homicidal ideation,~* expressed interest in methadone treatment,~* were required to use opioids for medical purposes,~* earned over $200 in taxable income over the previous 30 days,~* had physical limitations that would prevent them from using a keyboard, or were incarcerated or under constant monitoring by the criminal justice system.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Work Plus Naltrexone Prescription (Type: NO_INTERVENTION): Participants could work and earn vouchers but did not to take Vivitrol Injections to work and earn vouchers.
- Work Plus Naltrexone Contingency (Type: EXPERIMENTAL): Participants could work and earn vouchers and had to take Vivitrol Injections to work and earn vouchers: employment-based reinforcement.

Based on this trial design, predict the completion outcome and termination type (if applicable).